Tuesday, February 11, 2014
Open letter from public health clinicians, researchers, and academics regarding Uganda’s Anti-Homosexuality Bill
To His Excellency Yoweri Kaguta Museveni, President of the Republic of Uganda:
We, the undersigned, are writing out of grave concern regarding the likely implications of Uganda’s
Anti Homosexuality Bill (“the Bill”) should it be passed into law. We are clinicians, researchers and
academics working in the field of public health. Many of us have extensive experience providing
physical and mental health services and doing public health-focused research in sub-Saharan Africa.
We note that Ugandan experts, including Uganda’s Human Rights Commission and the Uganda Law
Society, have studied this Bill and found that it violates obligations under Uganda’s Constitution to
protect and uphold fundamental freedoms of its people. This Bill also contradicts scientific evidence
regarding lesbian, gay, bisexual and transgender people. In your letter sent on December 28 to the
Rt. Hon. Speaker of Parliament, Rebecca Kadaga, you have expressed an interest in deliberating
over evidence and science regarding sexual orientation and arriving at a “scientifically correct position”
on the Bill.1 The purpose of this open letter is to focus on areas of particular concern to us as
public health experts, beyond our fundamental support for the human rights and human dignity of all
Ugandans: 1) the overwhelming evidence about homosexuality and the myths perpetuated by the Bill
and 2) the likely public health implications of this Bill, should it become law in Uganda.
1. Myths and Facts About Homosexuality
Your December 28 letter questions: a) whether homosexuality is an abnormality and b) whether homosexuality
is a condition of which a person can be “cured” or “rescued.”2
Evidence from independent technical normative agencies and respected medical and sociological
professional bodies around the world could not be more clear in response to both
questions: Homosexuality is not a pathology, an abnormality, a mental disorder, or an illness—it is
a variant of sexual behavior found in people around the world. Lesbian, gay, bisexual, and
transgender people are normal. According to Uganda’s national diagnostics and statistical manual of
mental disorders (DSM), homosexuality is not classified as a mental disorder. Neither is homosexuality
a condition from which a person can be “converted.” Despite claims to the contrary, there is no
rigorous and peer reviewed scientific evidence that a person who is lesbian, gay, bisexual or
transgendered can be “cured.”3
The Bill’s claim to protect children and families in Uganda appears to be derived from the harmful
myth that lesbian, gay, bisexual and transgender people pose a graver risk to children and families
than people of other sexual orientations. There is no such evidence—lesbian, gay, bisexual and
transgender people pose no greater risk to children than heterosexuals. In fact, sexual and physical
violence experienced all too routinely by children and adolescents in Uganda would be unaddressed
by this Bill. Implementation of this Bill would likely deplete the already limited resources invested in
Uganda into robust investigations and prosecutions of cases of violence against children. Rather, the
limited funds would be wasted on hunts by police for consenting adults suspected or accused of being
lesbian, gay, bisexual or transgender.
2. Undermining public health and human rights
This Bill would further exacerbate the marginalization, discrimination and exclusion of people known
to or suspected of being homosexual. Research shows that laws and policies that increase stigma
1
The Daily Monitor, “Museveni blocks anti-homosexuality bill,” Yasiin Mugerwa. 17 January 2014.
http://www.monitor.co.ug/News/National/Museveni-blocks-Anti-Homosexuality-Bill/-/688334/2148760/-
/15lby8fz/-/index.html
2
Letter from President Museveni to Rt. Hon. Speaker Kadaga, 28 December 2013. Available at:
http://www.scribd.com/doc/200400880/President-Museveni-s-Letter-on-Anti-Homosexuality-Bill
3
Cf. Pan American Health Organisation (PAHO). “ ‘Cures’ For an Illness that Does Not Exist: Purported Therapies
Aimed at Changing Sexual Orientation Lack Medical Justification and are Ethically Unacceptable.” 15 May
2012, available at http://new.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=17703 and
Psychological Society of South Africa, “Sexual and Gender Diversity Position Statement,” 7 June 2013.
and discrimination among groups of people mean those people are less able to access health services
because of fear of arrest, intimidation, violence, and discrimination. For example, men who
have sex with men in Uganda report higher HIV prevalence and higher rates of syphilis and other
sexually transmitted infections than the general population.4 HIV prevalence among men who have
sex with men in Kampala is 13%, more than three times the average prevalence among heterosexual
men in Kampala (4.1%) and about twice as high as the national average of 7.3%. After years of
success in the fight against HIV, Uganda’s incidence has been rising since 2005—contrary to the
trends of virtually all other countries with high HIV burden in sub Saharan Africa.5 We are gravely
concerned that passage of this Bill will exacerbate that negative trend.
All people need essential health services, not the criminalization and discrimination this Bill would
foment. Furthermore, driving lesbian, gay, bisexual and transgender communities away from services
endangers not only them but also the Ugandan population at large—approximately 75% of
men who have sex with men participating in a recent serosurvey report having sex with women as
well as men.6 Discrimination undermines their health as well as the public health of the population of
Uganda as a whole.
Ironically, the Bill’s clause prohibiting the “promotion of homosexuality” as well as “aiding and abetting
homosexuality” would criminalize urgently needed service delivery for lesbian, gay, bisexual and
transgender people. The Government of Uganda recently announced plans to implement government
funded clinics designed to reach men who have sex with men and sex workers.7 This Bill, if
passed into law, would sabotage such efforts by criminalizing them. This will have a disastrous impact
on the response of the nation as a whole to HIV as well as other public health priorities. This
clause would also put international and national health service providers funded by international donors
at risk of criminal prosecution if they discuss homosexuality in the course of their work.
The Bill conflicts with a health worker’s basic ethical obligation not to discriminate in the provision of
medical services and would create a culture of fear of arrest and imprisonment among service providers.
While a clause in earlier versions of the Bill that anyone suspected of being homosexual be
reported to police might have been removed from the Bill that Parliament passed, the clause prohibiting
promotion, aiding and abetting homosexuality would still force health workers to discriminate.
Contrary to recent claims that health workers in Uganda do not engage in discrimination when
providing services, Ugandans seeking health services in the public and private sectors frequently
report being questioned by health workers about their sexual activities and marital status—creating
for LGBT populations a legitimate fear of retaliation and discrimination if they are honest about their
sexual orientation. This climate of fear would be markedly increased should the Bill become law.
Scientific research also shows a powerful association between homophobic abuse and violence and
increased vulnerability to HIV. This is not due to an intrinsic condition of homosexuality, but a harmful
effect of homophobia. For example, men who have sex with men in Kampala who have experienced
verbal or physical homophobic abuse are five times more likely to be HIV positive than men who
have sex with men who have not experienced such abuse,8 indicating a strong association between
stigma and intolerance and HIV infection risk. Hatred and stigma drives vulnerable and isolated
communities such as men who have sex with men further from essential preventative and curative
health services.
We believe this Bill should not be passed into law—it blatantly defies highly corroborated scientific
evidence and it would have a harmful impact on public health, human rights, and the freedom of all
4
Hladik W, Barker J, Ssenkusu JM, Opio A, Tappero JW, et al. (2012) HIV Infection among Men Who Have Sex
with Men in Kampala, Uganda–A Respondent Driven Sampling Survey. PLoS ONE 7(5): e38143.
doi:10.1371/journal.pone.0038143
5
WHO: Global HIV/AIDS Response, Epidemic Update and Health Sector Progress Towards Universal Access,
Progress Report, 2011. p. 12-17.
6
Supra note 4.
7
“Outrage, scepticism at Uganda U-turn on LGBTI clinics,” 9 Dec 2013. Available at:
http://www.irinnews.org/report/99289/outrage-scepticism-at-uganda-u-turn-on-lgbti-clinics
8
Supra note 4.
people to enjoy freedom from discrimination in Uganda. We implore that you veto this Bill in all
forms. We note that Ugandan politicians and policymakers will meet February 6 in Kyankwanzi,
Uganda where this issue will be discussed amongst the National Resistance Movement Caucus.
Representatives of our group of signatories request the opportunity to join you in Kyankwanzi to
share scientific evidence face-to-face, given the intense interest this topic has generated, apparent
misinformation among decision makers, and the Bill’s serious consequences for Ugandans should it
be passed into law.
Signed,
[list in formation]
Organizations:
International AIDS Society (IAS), Geneva, Switzerland
Southern African HIV Clinicians Society
HIV Medicine Association (HIVMA)
Infectious Diseases Society of America, Center for Global Health Policy
The Desmond Tutu HIV Centre, University of Cape Town, South Africa
The Desmond Tutu HIV Foundation, Cape Town, South Africa
The Civil Society Coalition on Human Rights and Constitutional Law, Uganda
Fenway Health, Boston, USA
Individuals:
Noerine Kaleeba, PhD
Founder and Patron
The AIDS Support Organisation
Uganda
Dr. Ian Clarke
Chairman and CEO
International Medical Group
Kampala, Uganda
Dr. Geoffrey Mujisha
Executive Director, MARPs Network
Kampala, Uganda
Edith Mukisa
Executive Director
Community Health Alliance Uganda
Kampala, Uganda
Dr. Stephen Watiti
Chairperson, Board of Directors
Community Health Alliance Uganda
Kampala, Uganda
Dennis Odwe
Executive Director
Action Group for Health, Human Rights and Development (AGHA) Uganda
Kampala, Uganda
Professor Hoosen Coovadia
Emeritus Professor of Paediatrics and Child Health,
Emeritus Victor Daitz Professor of HIV/AIDS Research,
University of KwaZulu-Natal
Director, Maternal Adolescent and Child Health,
University of the Witwatersrand
Commissioner, National Planning Commission, The Presidency
South Africa
Professor Helen Rees
Executive Director, Wits Reproductive Health and HIV Institute
University of the Witwatersrand
Johannesburg, South Africa
Professor Quarraisha Abdool Karim
Associate Scientific Director
Center for the AIDS Programme of Research in South Africa (CAPRISA)
Durban, South Africa
Sergii Dvoriak MD, Ph.D.
Head of the Board
Ukrainian Institute of Public Health Policy
Kiev, Ukraine
Richard E. Chaisson, MD
Professor of Medicine, Epidemiology and International Health
Director, Center for TB Research and Center for AIDS Research
Johns Hopkins University
Baltimore, USA
Professor Adeeba Kamarulzaman
Dean, Faculty of Medicine
University of Malaya
Kuala Lumpur, Malaysia
Professor Francois Venter
Deputy Executive Director, Wits Reproductive Health and HIV Institute
University of the Witwatersrand
Johannesburg, South Africa
Joel E. Gallant, MD, MPH
Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, USA
Allan Raggi
Executive Director
Kenya AIDS NGOs Consortium (KANCO)
Nairobi, Kenya
Professor Michael Adler, CBE
Emeritus Professor of Genitourinary Medicine and Sexually Transmitted Diseases
University College Medical School
London, UK
Casper W. Erichsen
Executive Director
Positive Vibes Trust
Windhoek, Namibia
Richard B. Krueger, MD
Medical Director, Sexual Behavior Clinic
New York State Psychiatric Institute & Columbia University Department of Psychiatry
Associate Clinical Professor of Psychiatry
Columbia University, Department of Psychiatry
New York, USA
Jens Lundgren, MD DMSc
Rigshospitalet, University of Copenhagen
Professor, Director of Copenhagen HIV Programme, Centre of Global Excellence (CHIP)
Department of Infectious Diseases and Rheumatology
Copenhagen, Denmark
Ambrose Agweyu, MBChB, MSc
Clinical Epidemiologist
Kenya Medical Research Institute
Nairobi, Kenya
Kenneth Mayer MD
Director of HIV Prevention Research
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Sten H. Vermund, MD, PhD
Amos Christie Chair of Global Health
Vanderbilt University School of Medicine
Nashville, USA
Coleen K. Cunningham, MD
Chief, Infectious Diseases Pediatrics
Chief, Global Health Pediatrics
Duke University Medical Center
Durham, USA
Professor Yousuf A Vawda
Academic Leader, Public Law
School of Law, University of KwaZulu-Natal
Durban, South Africa
Professor Jeam van Bergen, MD, MPh, PhD
Professor STI in Primary Care, University of Amsterdam-AMC
Department of General Practice
Amsterdam, The Netherlands
Jürgen Rockstroh, Professor of Medicine
Chair of the German National AIDS Council
Head of HIV-Clinic
Department of Medicine I
University of Bonn
Germany
Anand Pandya, MD
Vice Chair for Clinical Affairs, University of Southern California
Department of Psychiatry
Chief of Psychiatry, Los Angeles County General Hospital
Los Angeles, USA
Lisa Hirschhorn, MD MPH
Partners in Health
Harvard Medical School
Boston, USA
Professor Brook K. Baker
Northeastern University School of Law
Program on Human Rights and the Global Economy
Honorary Research Fellow, University of KwaZulu Natal, Durban, South Africa
Professor Linda-Gail Bekker
Professor of Medicine
Deputy Director, The Desmond Tutu HIV Centre
University of Cape Town
South Africa
Frederick L. Altice, MD
Professor of Medicine and Public Health
Yale University
New Haven, USA
Professor Aikichi Iwamoto, MD
Division of Infectious Diseases
Advanced Clinical Research Center
The Institute of Medical Science
The University of Tokyo (IMSUT)
Alvaro Bermejo, MD, MPH
Executive Director
International HIV/AIDS Alliance
Hove, UK
Dr Natasha Davies, MBBCH, HIV Management Diploma, MPH
Technical Specialist, Adult Care & Treatment
Wits Reproductive Health & HIV Institute
Johannesburg, South Africa
Andy Gray BPharm MSc (Pharm) FPS FFIP
Senior Lecturer, Division of Pharmacology
Discipline of Pharmaceutical Sciences
School of Health Sciences
Consultant Pharmacist (Research Associate)
Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-
Natal
South Africa
Stephen L. Boswell, MD
President and CEO
Fenway Health
Boston, MA
Assistant Professor of Medicine
Harvard Medical School
Melanie Thompson, MD
Principal Investigator
AIDS Research Consortium of Atlanta
Atlanta, USA
Lyn van Rooyen
Director, CABSA
Johannesburg, South Africa
Noah Metheny, MPH
Director of Policy
The Global Forum on MSM & HIV (MSMGF)
Wendy Armstrong, MD
Associate Professor of Medicine, Infectious Diseases
Emory University School of Medicine
Atlanta, USA
Wim Vandevelde
Global TB Community Advisory Board, Chair
Cape Town, South Africa
Professor Michael Meltsner
Matthews Distinguished University Professor of Law
Northeastern University School of Law
Boston, USA
Prof Roy Chan
President
Action for AIDS Singapore
Dr. Andrew Scheibe
HIV Key Populations Consultant
Cape Town, South Africa
Dr Michelle Moorhouse
Member, Board of Directors,
Southern African HIV Clinicians Society
Elizabeth Levy Paluck
Assistant Professor of Psychology and Public and International Affairs
Princeton University
Princeton, USA
Wendy E. Parmet
Associate Dean for Academic Affairs
Matthews Distinguished University Professor of Law
Northeastern University School of Law
Boston, USA
Polly Clayden
HIV i-Base
London, UK
Veronica Miller, PhD
Director, Forum for Collaborative HIV Research
Visiting Professor, University of California, Berkeley School of Public Health
USA
Benjamin Hauschild, MPH
Senior Research Associate, Forum for Collaborative HIV Research
University of California, Berkeley School of Public Health
USA
Professor Gwynne Skinner
Willamette University College of Law
Salem, USA
Keith M Mullei, MPH
Health systems and health policy researcher
Nairobi, Kenya
Christine L. Lin
Clinical Instructor and Staff Attorney
Center for Gender & Refugee Studies
Refugee & Human Rights Clinic
University of California, Hastings College of the Law
San Francisco, USA
Deborah A. Ramirez
Professor of Law
Northeastern University School of Law
Boston, USA
Francisco J. Rivera Juaristi
Director, International Human Rights Clinic
Assistant Clinical Professor of Law
Santa Clara University School of Law
Santa Clara, USA
Stephen A. Rosenbaum
Visiting Senior Lecturer, University of Washington School of Law
John & Elizabeth Boalt Lecturer, University of California, Berkeley School of Law
USA
Felicia Price, RN, BSN, MIA
Technical Advisor - Community Health and HIV
Christian Aid
Bujumbura, Burundi
Judith D. Auerbach, PhD
Adjunct Professor
School of Medicine
University of California
San Francisco, USA
Anna Forbes, MSS
Independent consultant specializing in HIV, rights, women and gender
Washington DC, USA
Rosalind P. Petchesky
Distinguished Professor of Political Science (Emerita)
Hunter College & the Graduate Center, City University of New York
USA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment